Antimicrobial activity of clofazimine is not dependent on mycobacterial C-type phospholipases.
M C Bopape, H C Steel, R Cockeran, N M Matlola, P B Fourie, R Anderson
Index: J. Antimicrob. Chemother. 53(6) , 971-4, (2004)
Full Text: HTML
Abstract
We have used a phospholipase C (PLC)-deletion mutant (plcABC) of the H37Rv strain of Mycobacterium tuberculosis (MTB), as well as a plcA-insertion mutant of Mycobacterium smegmatis, to investigate the possible involvement of PLCs in clofazimine-mediated inhibition of mycobacterial K(+) transport and growth. Inactivation of the PLCs of MTB and insertion of the plcA gene into M. smegmatis resulted in a substantial reduction and increase in hydrolysis of phosphatidylcholine (PC), respectively. However, both the mutant and wild-type strains of MTB and M. smegmatis were equally sensitive to the inhibitory effects of clofazimine on K(+) uptake and growth. These observations demonstrate that the PLCs of MTB are not involved in the antimicrobial activity of clofazimine.
Related Compounds
Related Articles:
2005-03-01
[Am. J. Physiol. Lung Cell. Mol. Physiol. 288(3) , L460-70, (2005)]
2008-07-01
[J. Cell Physiol. 216(1) , 91-100, (2008)]
2004-09-19
[Eur. J. Pharmacol. 499(1-2) , 99-105, (2004)]
2008-03-17
[Eur. J. Pharmacol. 582(1-3) , 62-9, (2008)]
2011-08-12
[Biochem. Biophys. Res. Commun. 411(4) , 809-14, (2011)]